Project Details
Description
Objectives:
To create a stable cell line expressing human NaV1.8 voltage-gated sodium channels with or without human sodium channel β subunits (β1, β2) for use in high throughput screening. An innovative transposon approach developed in the Study Director’s laboratory will be used to insure a high probability of success and robust expression. A similar approach was successful in generating stable cell lines expressing the NaV1.9 sodium channel.
Status | Finished |
---|---|
Effective start/end date | 7/9/14 → 3/31/15 |
Funding
- Merck Sharp & Dohme Corporation (Agmt 7/9/14)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.